Slimmer’s Paralysis in GLP-1 Therapy: Prevention Strategies

This presentation explores Slimmer’s Paralysis, a rare complication linked to the use of GLP-1 receptor agonists for obesity treatment. Topics include the mechanisms behind rapid weight loss effects such as compression neuropathy, nutritional deficiencies, and adipose tissue loss. A meta-analysis of 380 cases provides insight into associated challenges and outcomes. Effective management strategies, including interventions and symptom monitoring, are discussed alongside the importance of...